Molecular intelligence / emerging research
These compounds aren't necessarily available through OnimaChain. They're here because the research around them is moving and worth following.
10 tracked molecules · none listed for sale · each development label links to a dated source
Find by target, developer, or research stage
Watchlist · compound
Also known as Amycretin
One investigational molecule designed to engage GLP-1 and amylin receptor systems.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
Also known as ZP8396
An investigational long-acting amylin analogue.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
Also known as CT-388, RO7795068
An investigational molecule acting at both the GLP-1 and GIP receptors.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
An investigational dual GLP-1/GIP receptor agonist.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
A long-acting amylin analogue studied alone and with semaglutide.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
Also known as IBI362
A dual GLP-1 and glucagon receptor agonist; regulatory status varies by jurisdiction.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
Also known as PF’3944, MET-097i
An investigational long-acting GLP-1 receptor agonist peptide.
Conceptual visualization · no verified coordinates rendered
Watchlist · compound
Also known as ALT-801
An investigational peptide acting at GLP-1 and glucagon receptors.
Conceptual visualization · no verified coordinates rendered
Watchlist profiles are informational. Inclusion does not mean a compound is available from OnimaChain or approved for use. Development status varies by indication and jurisdiction; dates and sources are shown with each entry. Conceptual target visuals are not experimental molecular structures.